Literature DB >> 19325608

The dangers of diagnostic monopolies.

Robert Cook-Deegan1, Subhashini Chandrasekharan, Misha Angrist.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19325608      PMCID: PMC2702156          DOI: 10.1038/458405a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  4 in total

1.  A pilot survey on the licensing of DNA inventions.

Authors:  Michelle R Henry; Mildred K Cho; Meredith A Weaver; Jon F Merz
Journal:  J Law Med Ethics       Date:  2003       Impact factor: 1.718

2.  Effects of patents and licenses on the provision of clinical genetic testing services.

Authors:  Mildred K Cho; Samantha Illangasekare; Meredith A Weaver; Debra G B Leonard; Jon F Merz
Journal:  J Mol Diagn       Date:  2003-02       Impact factor: 5.568

3.  Intellectual property. Enhanced: intellectual property landscape of the human genome.

Authors:  Kyle Jensen; Fiona Murray
Journal:  Science       Date:  2005-10-14       Impact factor: 47.728

4.  Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.

Authors:  Tom Walsh; Silvia Casadei; Kathryn Hale Coats; Elizabeth Swisher; Sunday M Stray; Jake Higgins; Kevin C Roach; Jessica Mandell; Ming K Lee; Sona Ciernikova; Lenka Foretova; Pavel Soucek; Mary-Claire King
Journal:  JAMA       Date:  2006-03-22       Impact factor: 56.272

  4 in total
  15 in total

1.  Gene patents on the line.

Authors:  Bob Carlson
Journal:  Biotechnol Healthc       Date:  2009-10

2.  Are the gene-patent storm clouds dissipating? A global snapshot.

Authors:  Johnathon Liddicoat; Tess Whitton; Dianne Nicol
Journal:  Nat Biotechnol       Date:  2015-04       Impact factor: 54.908

Review 3.  The fate and future of patents on human genes and genetic diagnostic methods.

Authors:  Isabelle Huys; Gert Matthijs; Geertrui Van Overwalle
Journal:  Nat Rev Genet       Date:  2012-05-18       Impact factor: 53.242

4.  Intellectual property rights in publicly funded biobanks: much ado about nothing?

Authors:  Saminda Pathmasiri; Mylène Deschênes; Yann Joly; Tara Mrejen; Francis Hemmings; Bartha Maria Knoppers
Journal:  Nat Biotechnol       Date:  2011-04       Impact factor: 54.908

5.  It's about scientific secrecy, dummy: a better equilibrium among genomics patenting, scientific research and health care.

Authors:  Miriam Bentwich
Journal:  Sci Eng Ethics       Date:  2011-02-13       Impact factor: 3.525

6.  Changing the rules of the game: addressing the conflict between free access to scientific discovery and intellectual property rights.

Authors:  Miriam Bentwich
Journal:  Nat Biotechnol       Date:  2010-02       Impact factor: 54.908

Review 7.  Do recent US Supreme Court rulings on patenting of genes and genetic diagnostics affect the practice of genetic screening and diagnosis in prenatal and reproductive care?

Authors:  Subhashini Chandrasekharan; Amy L McGuire; Ignatia B Van den Veyver
Journal:  Prenat Diagn       Date:  2014-07-31       Impact factor: 3.050

8.  Harm, hype and evidence: ELSI research and policy guidance.

Authors:  Timothy Caulfield; Subhashini Chandrasekharan; Yann Joly; Robert Cook-Deegan
Journal:  Genome Med       Date:  2013-03-26       Impact factor: 11.117

9.  Are patents impeding medical care and innovation?

Authors:  E Richard Gold; Warren Kaplan; James Orbinski; Sarah Harland-Logan; Sevil N-Marandi
Journal:  PLoS Med       Date:  2010-01-05       Impact factor: 11.069

10.  Gene patents and personalized medicine - what lies ahead?

Authors:  Subhashini Chandrasekharan; Robert Cook-Deegan
Journal:  Genome Med       Date:  2009-09-28       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.